News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233,651 Results
Type
Article (7579)
Company Profile (47)
Press Release (226025)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (72409)
Career Advice (214)
Deals (15767)
Drug Delivery (10)
Drug Development (30972)
Employer Resources (13)
FDA (5185)
Job Trends (5437)
News (123178)
Policy (10712)
Tag
Academia (803)
Accelerated approval (3)
Adcomms (1)
Allergies (30)
Alliances (12310)
ALS (35)
Alzheimer's disease (511)
Antibody-drug conjugate (ADC) (38)
Approvals (5299)
Artificial intelligence (56)
Autoimmune disease (8)
Automation (5)
Bankruptcy (120)
Best Places to Work (4984)
BIOSECURE Act (3)
Biosimilars (17)
Biotechnology (33)
Bladder cancer (32)
Brain cancer (9)
Breast cancer (146)
Cancer (1082)
Cardiovascular disease (80)
Career advice (189)
Career pathing (4)
CAR-T (70)
CDC (2)
Cell therapy (159)
Cervical cancer (10)
Clinical research (26320)
Collaboration (248)
Company closure (1)
Compensation (187)
Complete response letters (2)
COVID-19 (1156)
CRISPR (16)
C-suite (62)
Cystic fibrosis (36)
Data (1326)
Depression (23)
Diabetes (113)
Diagnostics (2428)
Digital health (10)
Diversity, equity & inclusion (1)
Drug discovery (34)
Drug pricing (10)
Drug shortages (3)
Duchenne muscular dystrophy (41)
Earnings (45563)
Editorial (8)
Employer branding (3)
Employer resources (13)
Events (39062)
Executive appointments (169)
FDA (5881)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (5)
Funding (206)
Gene editing (38)
Generative AI (3)
Gene therapy (82)
GLP-1 (208)
Government (1606)
Grass and pollen (1)
Guidances (146)
Healthcare (7530)
HIV (16)
Huntington's disease (10)
IgA nephropathy (9)
Immunology and inflammation (41)
Indications (16)
Infectious disease (1213)
Inflammatory bowel disease (57)
Influenza (21)
Intellectual property (40)
Interviews (30)
IPO (10400)
IRA (3)
Job creations (660)
Job search strategy (163)
Kidney cancer (4)
Labor market (13)
Layoffs (98)
Leadership (2)
Legal (2069)
Liver cancer (28)
Longevity (4)
Lung cancer (157)
Lymphoma (91)
Machine learning (3)
Management (5)
Manufacturing (77)
MASH (41)
Medical device (5485)
Medtech (5485)
Mergers & acquisitions (5663)
Metabolic disorders (262)
Multiple sclerosis (32)
NASH (10)
Neurodegenerative disease (31)
Neuropsychiatric disorders (7)
Neuroscience (708)
NextGen: Class of 2025 (1700)
Non-profit (1360)
Now hiring (6)
Obesity (116)
Opinion (20)
Ovarian cancer (40)
Pain (28)
Pancreatic cancer (45)
Parkinson's disease (48)
Partnered (5)
Patents (90)
Patient recruitment (46)
Peanut (19)
People (14217)
Pharmaceutical (11)
Pharmacy benefit managers (1)
Phase I (7439)
Phase II (11495)
Phase III (9766)
Pipeline (990)
Policy (14)
Postmarket research (889)
Preclinical (2757)
Press Release (15)
Prostate cancer (52)
Psychedelics (6)
Radiopharmaceuticals (107)
Rare diseases (134)
Real estate (1242)
Recruiting (7)
Regulatory (7928)
Reports (10)
Research institute (629)
Resumes & cover letters (21)
Rett syndrome (2)
RNA editing (1)
RSV (17)
Schizophrenia (33)
Series A (31)
Series B (24)
Service/supplier (6)
Sickle cell disease (18)
Special edition (9)
Spinal muscular atrophy (81)
Sponsored (5)
Startups (661)
State (1)
Stomach cancer (1)
Supply chain (20)
Tariffs (11)
The Weekly (3)
Vaccines (210)
Venture capital (12)
Weight loss (41)
Women's health (8)
Worklife (2)
Date
Today (23)
Last 7 days (102)
Last 30 days (596)
Last 365 days (11625)
2025 (6209)
2024 (13243)
2023 (15223)
2022 (18850)
2021 (20145)
2020 (41848)
2019 (15554)
2018 (10708)
2017 (10568)
2016 (8595)
2015 (11194)
2014 (7511)
2013 (5238)
2012 (6055)
2011 (6579)
2010 (5737)
Location
Africa (140)
Alabama (29)
Alaska (1)
Arizona (46)
Arkansas (1)
Asia (14171)
Australia (2036)
California (2928)
Canada (715)
China (222)
Colorado (137)
Connecticut (141)
Delaware (95)
Europe (28762)
Florida (430)
Georgia (78)
Idaho (11)
Illinois (220)
India (4)
Indiana (150)
Iowa (3)
Japan (73)
Kansas (59)
Kentucky (6)
Louisiana (7)
Maine (26)
Maryland (324)
Massachusetts (1927)
Michigan (81)
Minnesota (153)
Mississippi (1)
Missouri (42)
Montana (8)
Nebraska (6)
Nevada (20)
New Hampshire (22)
New Jersey (991)
New Mexico (6)
New York (825)
North Carolina (333)
North Dakota (5)
Northern California (1348)
Ohio (72)
Oklahoma (2)
Oregon (5)
Pennsylvania (658)
Puerto Rico (1)
Rhode Island (5)
South America (258)
South Carolina (5)
Southern California (1111)
Tennessee (18)
Texas (431)
United States (10420)
Utah (80)
Virginia (82)
Washington D.C. (7)
Washington State (230)
West Virginia (1)
Wisconsin (12)
233,651 Results for "21".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
U.S. Allergy Diagnostics and Therapeutics Market Size to Hit USD 21.20 Billion by 2034
July 17, 2025
·
1 min read
Mergers & acquisitions
AbbVie Plunks Down $2.1B for Capstan and Its Novel CAR T Therapies
The all-cash buyout, which gives AbbVie access to Capstan Therapeutics’
in vivo
edited CAR T therapy for B cell–mediated autoimmune diseases, adds to a growing sense of momentum in M&A, according to BMO Capital Markets.
June 30, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025
June 24, 2025
·
1 min read
Press Releases
Lifeward to Present at Sidoti Virtual Investor Conference on May 21
May 19, 2025
·
1 min read
Press Releases
Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery
Signs on Eight Pharmaceutical Partners and Completes First Preclinical Study from Immune Organoid Platform with Centivax
June 12, 2025
·
1 min read
Press Releases
Thermo Fisher Scientific Declares Quarterly Dividend - May 21, 2025
May 22, 2025
·
1 min read
Press Releases
CEL-SCI Announces Proposed Public Offering - May 21, 2025
May 22, 2025
·
4 min read
Press Releases
CEL-SCI Announces Pricing of Public Offering - May 21, 2025
May 22, 2025
·
4 min read
Press Releases
Ipsen S.A. - Annual General Meeting held on 21 May 2025
May 22, 2025
·
6 min read
Press Releases
Andersen Disease Market Size to Reach USD 2.1 Billion by 2035, Impelled by Advancements in Gene Therapies
In the year 2024, 7 key markets of the andersen disease market amounted to USD 1.2 Billion. IMARC Group forecast that the same is expected to reach USD 2.1 Billion for 7MM by 2035, by exhibiting a CAGR of 5.71% during the forecast period, which is 2025-2035
January 23, 2025
·
9 min read
1 of 23,366
Next
